Crescent Biopharma, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2013 | $2.4M | $5.3M | $2.3M |
| FY2014 | $6.5M | $57.3M | $55.2M |
| FY2015 | $8.0M | $48.5M | $46.8M |
| FY2016 | $7.1M | $42.4M | $40.0M |
| FY2017 | $8.9M | $128.6M | $123.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2013 | $2.4M | $5.3M | $2.3M |
| FY2014 | $6.5M | $57.3M | $55.2M |
| FY2015 | $8.0M | $48.5M | $46.8M |
| FY2016 | $7.1M | $42.4M | $40.0M |
| FY2017 | $8.9M | $128.6M | $123.9M |